For example, CASC4 levels may be used to predict the efficacy of immune checkpoint inhibitors, which target cell surface proteins, whose presence at the plasma membrane may be CASC4-regulated; ovarian cancers, while highly immunogenic, have poor response rates to such therapies [43]. The gene discussed is GOLM2; the disease is ovarian carcinoma.